CFG
Cooper Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.62M | Sell |
3,644
-993
| -21% | -$442K | 0.19% | 92 |
|
|
2025
Q1 | $2.25M | Sell |
4,637
-45
| -1% | -$21.8K | 0.3% | 64 |
|
|
2024
Q4 | $1.89M | Buy |
4,682
+651
| +16% | +$262K | 0.23% | 84 |
|
|
2024
Q3 | $1.87M | Buy |
4,031
+284
| +8% | +$132K | 0.24% | 73 |
|
|
2024
Q2 | $1.76M | Buy |
3,747
+120
| +3% | +$56.2K | 0.26% | 71 |
|
|
2024
Q1 | $1.52M | Buy |
3,627
+400
| +12% | +$167K | 0.25% | 80 |
|
|
2023
Q4 | $1.31M | Buy |
3,227
+207
| +7% | +$84.2K | 0.24% | 79 |
|
|
2023
Q3 | $1.05M | Buy |
3,020
+29
| +1% | +$10.1K | 0.25% | 98 |
|
|
2023
Q2 | $1.05M | Buy |
2,991
+297
| +11% | +$105K | 0.26% | 89 |
|
|
2023
Q1 | $849K | Buy |
2,694
+230
| +9% | +$72.5K | 0.23% | 107 |
|
|
2022
Q4 | $712K | Buy |
2,464
+466
| +23% | +$135K | 0.22% | 111 |
|
|
2022
Q3 | $579K | Buy |
1,998
+917
| +85% | +$266K | 0.21% | 116 |
|
|
2022
Q2 | $305K | Buy |
1,081
+122
| +13% | +$34.4K | 0.11% | 180 |
|
|
2022
Q1 | $250K | Buy |
959
+22
| +2% | +$5.74K | 0.1% | 202 |
|
|
2021
Q4 | $206K | Buy |
+937
| New | +$206K | 0.08% | 225 |
|